8:00AM Sunesis Pharma priced a 44.1 mln unit offering, each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a public offering price of $0.35/unit, for gross proceeds of approximately $15.5 mln (SNSS) 0.42 :
News 
Market Data 
Discover 
